Prototrophic revertants of a trpD deletion mutant that lacks the glutamine amidotransferase domain of the bifunctional component II subunit of the anthranilate synthetase-phosphoribosyltransferase complex have been found to arise by the occurrence of sublethal missense mutations in either the pheA or tyrA loci. Such suppressor mutations were obtained directly by mutation of the wild-type pheA gene as well as indirectly by partial reversion of a variety of nonleaky pheA and tyrA mutations. The suppressor strains have only a portion of the normal level of the pheA or tyrA enzyme activity and thus experience a partial limitation in the synthesis of phenylalanine or tyrosine. This limitation leads to a relaxation of end-product regulation of the phenylalanine-or tyrosine-specific enzymes of the common aromatic pathway and to the overproduction of the branch point intermediate, chorismic acid, which is one of the substrates of the anthranilate synthetase reaction. It is proposed that the high intracellular level of chorismic acid acts to elevate the non-physiological NH3-dependent anthranilate synthetase activity of the component I subunit, thereby eliminating the need for the glutamine amidotransferase activity of the component II subunit. Consistent with this is the finding that phenylalanine and tyrosine are specific inhibitors of growth of the pheA and tyrA suppressor strains, respectively, causing a shutdown of the overproduction of chorismic acid by reestablishing normal end-product control of the common pathway.
Prototrophic revertants of a trpD deletion mutant that lacks the glutamine amidotransferase domain of the bifunctional component II subunit of the anthranilate synthetase-phosphoribosyltransferase complex have been found to arise by the occurrence of sublethal missense mutations in either the pheA or tyrA loci. Such suppressor mutations were obtained directly by mutation of the wild-type pheA gene as well as indirectly by partial reversion of a variety of nonleaky pheA and tyrA mutations. The suppressor strains have only a portion of the normal level of the pheA or tyrA enzyme activity and thus experience a partial limitation in the synthesis of phenylalanine or tyrosine. This limitation leads to a relaxation of end-product regulation of the phenylalanine-or tyrosine-specific enzymes of the common aromatic pathway and to the overproduction of the branch point intermediate, chorismic acid, which is one of the substrates of the anthranilate synthetase reaction. It is proposed that the high intracellular level of chorismic acid acts to elevate the non-physiological NH3-dependent anthranilate synthetase activity of the component I subunit, thereby eliminating the need for the glutamine amidotransferase activity of the component II subunit. Consistent with this is the finding that phenylalanine and tyrosine are specific inhibitors of growth of the pheA and tyrA suppressor strains, respectively, causing a shutdown of the overproduction of chorismic acid by reestablishing normal end-product control of the common pathway.
The trpD gene of Salmonella typhimurium (the revised nomenclature for the trp genes of S. typhimurium [28] is used here) encodes one of the two subunits of the multifunctional anthranilate synthetase (AS; EC 4.1.3.27)-phosphoribosyl transferase (PRT; EC 2.4.2.18) complex which catalyzes the first two steps of tryptophan (Trp) biosynthesis ( Fig. 1) (1, 15, 37) . The trpD polypeptide, referred to as component II of the complex, is bifunctional and has been shown to possess two independent structural domains (12, 16, 38) . One catalytic role of the component II subunit is in the AS reaction, where it acts as a glutamine amidotransferase (GAT), transferring the amide group ofglutamine to the NH3 binding site of the component I subunit, encoded by trpE (25) . Component I then uses the transferred NH3 for the amination of the common aromatic precursor, chorismic acid, in the synthesis of anthranilic acid (Anth). The GAT activity of component II, as well as the structural sites involved in its assembly with component I, reside in the amino-terminal 40% of the polypeptide (coded by region 1 of trpD) (12) . The carboxy-terminal 60% of component II (coded by region 2 of trpD) constitutes the second structural domain, which is responsible for the PRT activity of the complex (11, 12, 22) .
The utilization of glutamine as a source of NH3 for amination reactions, as typified in the AS reaction, is a common metabolic event (see Prusiner and Stadtman [27] ). It has been proposed that this manifold role of glutamine may have evolved by the coupling of GAT entities to existing aminases, perhaps as the ability of the primitive cell to procure or use free NH3 decreased- (12, 23, 33, 37) . According to this hypothesis, the GAT components of certain functionally distinct enzymes should have close structural homology, since it would be expected that they arose by the duplication and divergent evolution of the same ancestral gene.
In our efforts to test this hypothesis experimentally, we have discovered that prototrophic derivatives of a trpD region 1 (25) .
Excretion of chorismic acid. Cells were grown in the same manner as for the measurement of doubling time except that the volume of medium was 40 ml. Samples of 1.0 ml were taken at intervals and centrifuged, and the supernatant was assayed for the presence of chorismic acid by its quantitative conversion SUPPRESSION OF trpD DELETION 575 to Anth by homogeneous wild-type AS-PRT complex using the standard glutamine-dependent AS assay procedure (13 Phe. It was also found that Anth, which satisfies the nutritional requirement of TB662, reverses the Phe inhibition of TB751, whereas Tyr has no effect.
The actual rates of growth of these strains in various liquid media were then determined (Table 3). The very slow, leaky growth in MM exhibited by TB662 is characteristic of all mutants of region 1 of trpD (32) . The growth rate of TB751 is markedly higher than that of TB662, yet is still less than that of wild type. Supplementation with Trp stimulates the growth of TB751 but does not completely restore it to the wild-type rate, as it does with TB662. Conversely, supplementation with Phe drastically reduces the growth rate of TB751, an effect that is completely reversed by Trp. It is significant that it is only under these latter conditions (i.e., Trp + Phe) that the full wild-type growth rate is reestablished. Thus it appears that the unlinked mutation in TB751 that establishes the Phe-sensitive suppression of AtrpD1655 also causes a partial deficiency in the biosynthesis of Phe.
Mapping and characterization of the Phesensitive suppressor gene of TB751. Since it is known that a single enzyme, coded by the pheA locus, catalyzes the first two specific steps of the Phe biosynthetic pathway (Fig. 1) Table 2 .
Suppressors of AtrpDl655 among revertants of tyrA mutants. Analogous to the pheA CM-P-PDHA of the Phe pathway, a Tyr-specific enzyme (CM-T-PDHO), coded by tyrA, is known to carry out the first two specific steps of Tyr biosynthesis (6) (Fig. 1) Enzyme activities of suppressor strains. As outlined in Fig. 1 , pheA codes for the CM-P-PDHA of the Phe pathway, whereas tyrA codes for the CM-T-PDHO of the Tyr pathway (6, 29) . To correlate nutritional properties with pheA and tyrA expression, the CM, PDHA, and PDHO activities were analyzed in vitro in suppressor strains TB751 pheA867 AtrpD1655, TB775 pheA15Rl AtrpD1655, and TB760 tyrA827R5 AtrpD1655 and in their respective parental strains, TB662 AtrpDl655, TB724 pheA15 AtrpD1655, and TB735 tyrA827 AtrpD1655 (Table 4) .
TB751 was found to have only about 60% of the PDHA and CM activity of the TB662 control, verifying the conclusion drawn from the nutritional studies that this suppressor carries a partial block in the pheA gene. Since the CM-P and CM-T isozymes were not assayed individually, it is not certain that the concomitant reduction in total CM activity is due to a specific reduction in CM-P, although this is not an unreasonable assumption. PDHO activity of TB751 was similar to that of the control as expected.
The results obtained with the double-revertant suppressor strains, TB775 and TB760, are also consistent with the conclusions drawn from the nutritional studies. TB775, the Phe-sensitive strain, showed a partial restoration of PDHA activity (27% of the TB662 control level), which on October 28, 2017 by guest http://jb.asm.org/ was completely lacking in the TB724 parent. Similarly, TB760, the Tyr-sensitive strain, had a partially restored PDHO activity (25% of the TB662 control level), which was totally absent in its parent, TB735. Again, a quantitative assessment of the CM activities of these strains was made difficult by the complexity ofthepheA and tyrA loci and by the fact that CM-P and CM-T were not assayed independently in these experiments. The CM and PDHO activities of control TB724 and the CM and PDHA activities of control TB735 appear to be significantly higher than expected when compared with the respective activities of double revertants TB775 and TB760. This is most likely a regulatory phenomenon in that, under the conditions of growth used here, a greater degree of derepression of the enzymes would be expected to occur in the two nonleaky parental auxotrophs than in the two bradytrophic derivatives. Separate determination of the AS component I, AS component II, and PRT activities of the strains of Table 4 grown under a variety of conditions revealed no significant differences (data not shown). In this respect, all the pheA and tyrA derivatives were indistinguishable from TB662 AtrpDl655.
Excretion of chorismic acid by suppressor strains. Since the Trp, Phe, and Tyr biosynthetic pathways share chorismic acid as a common precursor, it was considered that the partial blocks in the pheA and tyrA genes of the suppressor strains might lead to an accumulation of chorismate in the cell, which in turn might be involved in the mechanism of suppression of AtrpDl655. This possibility was explored by testing for the excretion of chorismate into the culture medium during growth of a representative Phe-sensitive and Tyr-sensitive suppressor strain (Fig. 2) . It was found that suppressors TB751 pheA867 AtrpD1655 (Fig. 2a) and TB760 tyrA827R5 AtrpD1655 (Fig. 2b) do indeed excrete substantial amounts of chorismate during the initial stages of growth in MM. This is in contrast to the parental strain, TB662 Fig. 2a and 3a for the case of TB751). These effects appear to be due at least in part to a switch in the metabolism of the cultures growing in MM such that the' chorismate formed by the pathway is no longer excreted but begins to be converted in an effi-VOL. 139, 1979 cient manner to Phe and Tyr. This is indicated by the finding that, instead of chorismate, large amounts of Phe and Tyr are accumulated in the medium during the terminal stages of growth (data not presented). It has been established that this overproduction of Phe and Tyr is determined by the AtrpD1655 allele of these strains, since the effect is totally absent in TB755, which carries only the pheA867 marker, and is even more pronounced in TB662, which carries only the AtrpD1655 marker. In addition, the effect disappears when these strains are grown in MM + Trp. These results are consistent with the report that the excretion of Phe and Tyr is a general property of Trp auxotrophs cultivated in the absence of Trp (36) .
Since Trp relieves the Phe sensitivity of TB751 pheA867 AtrpDl655 and the Tyr sensitivity of TB760 tyrA827R5 AtrpD1655, it was possible to test whether the Phe and Tyr reversal of chorismate excretion seen in Fig. 2 is independent of the inhibitory effect of each on cellular growth (Fig. 3) . In the control experiments it was found that supplementation with Trp alone elevates the growth rates of suppressor strains TB751 and TB760 and of control strain TB662 AtrpD1655 as expected, but does not qualitatively alter their chorismate excretion patterns ( Fig. 3a and b) , although the extent of the accumulation was found to fluctuate somewhat from experiment to experiment. In the case of the Phe-sensitive suppressor, TB751, supplementation with Phe plus Trp stimulated the growth rate even more and completely eliminated the excretion of chorismate (Fig. 3a) . This (Fig. 3b) ; however, in this case it is Tyr plus Trp that specifically establishes the full growth rate and eliminates chorismate accumulation.
These results show that chorismate excretion is a direct result of the leaky pheA or tyrA mutation of the suppressor strains. Since the overproduction of chorismate is specifically shut off by Phe or Tyr in these strains, it appears likely that the Phe or Tyr sensitivity of the strains in MM is related to this shutoff, which in turn implies that the overproduction of chorismate is involved in the mechanism of suppression of AtrpD1655.
DISCUSSION
The isolation and characterization of suppressor mutations of a deletion of the trp biosynthetic operon are described here. Other instances of intergenic suppression of deletion mutations have been reported in bacteria, for example in the lac operon of E. coli (3) and in the leu (19, 20) and proAB (17, 21) As shown in Fig. 1 , trpD codes for the bifunctional (GAT-PRT) component II subunit of the AS-PRT complex. Region 1 of trpD specifies the GAT domain of component II (12, 32) , which acts in a complex with component I in carrying out the synthesis of Anth from glutamine and chorismic acid (37) . Suppression of the trpD1655 deletion by the pheA and tyrA mutations clearly does not involve the creation of a new, alternate pathway for Trp biosynthesis, since a functional component I must be present in the cell for suppression to occur. Rather, the suppressor mutations appear to act indirectly by leading to the overproduction and intracellular accumulation of chorismic acid. We postulate that this increased intracellular pool of chorismate acts on October 28, 2017 by guest http://jb.asm.org/ Downloaded from kinetically to elevate the non-physiological NH3-dependent AS activity of the component I subunit (Fig. 1) to a level sufficient for near-normal growth. This is consistent with the results of previous studies of the kinetic properties of the uncomplexed and complexed forms of component I (25, 39) , where it was found that under optimal conditions in vitro the Michaelis constant for chorismic acid in the NH3-dependent reaction is about 50-fold higher for the uncomplexed subunit. Unfortunately it is not possible to test directly whether exogenously supplied chorismic acid is similarly effective in relieving the AtrpD1655 auxotrophy, since this compound is not transported into the cell from the medium (26) and is unstable in solution (9) . However, it has been shown in E. coli that the early aromatic pathway can influence Trp biosynthesis in a somewhat analogous manner (14) . In this case a mutation rendering the early pathway insensitive to feedback inhibition by Phe leads to the overproduction of chorismate and thereby to resistance of the strain to the antimetabolite 3-methylanthranilate, a false feedback inhibitor of AS that acts competitively with chorismic acid.
A plausible explanation for the overproduction of chorismic acid by the pheA and tyrA suppressor strains and for their sensitivity to growth inhibition by Phe and Tyr, respectively, can be inferred from the mode of regulation of aromatic amino acid synthesis in enteric bacteria (recently reviewed by Umbarger [34] ). A major point of control is the first step of the common pathway, the synthesis of 3-deoxy-D-arabinoheptulosonic acid 7-phosphate (DAHP) (Fig. 1) . S. typhimurium possesses three DAHP synthetase (DAHPS) isozymes, distinguishable by their sensitivity to end-product inhibition (7) . DAHPS-Phe, DAHP-Tyr, and DAHP-Trp are specifically inhibited by Phe, Tyr, and Trp, respectively. Besides feedback inhibition of enzymatic activity, the synthesis of the DAHPS isozymes is also specifically repressed by the three amino acids (7, 34) . It follows, then, that the intracellular limitation of any one of these three amino acids would lead simultaneously to derepression of the synthesis of the appropriate DAHPS and to relief from feedback control of its activity, resulting in the increased production of chorismic acid, the first branch-point intermediate of the pathway.
Since the suppressor mutations cause a partial impairment in the activity of either the pheA or tyrA enzyme ( (Table 3 ) is supportive of this idea. Such a liinitation of Phe or Tyr synthesis should lead therefore to a corresponding relaxation of control of the Phe or Tyr component of the common pathway and to the observed overproduction of chorismic acid. It also follows that exogenously supplied Phe or Tyr would reestablish stringent control of the common pathway, thereby shutting off the excessive synthesis of chorismic acid, as observed (Fig. 2) . Thus Phe and Tyr would act as growth inhibitors of the pheA and tyrA suppressor strains, respectively, since they specifically eliminate the mechanism of enhancement of the NH3-dependent AS activity of component I. The observed reversal of the inhibition by Trp or Anth (Table 2 and 3) without a concomitant reversal of the shutoff of chorismate synthesis (Fig. 3) is consistent with this.
It is significant that all mutants of trpD region 1 in S. typhimurium (1, 32) and E. coli (18, 35) , no matter whether deletion or single-site types, are bradytrophic, growing in MM at about the same slow rate as reported here for deletion strain TB662 AtrpD1655. This leaky growth has been attributed to the slow NH3-dependent synthesis of Anth by the uncomplexed component I present in such strains. This is supported by the fact that these mutants become nonleaky in NH3-limited media (40) . That trpD region 1 mutants are recognized as Trp auxotrophs at all is probably due to the fact that the DAHPS-Trp isozyme is a minor enzyme, accounting for only a small fraction of the total DAHPS activity of the cell (7). The low level of chorismate accumulation by TB662 AtrpDl655 while growing in MM (Fig. 2) 
